Items Tagged ‘classical’

March 22, 2018

FDA Approves Adcetris® in Combination with Chemotherapy for Previously Untreated Stage III or IV Classical Hodgkin Lymphoma


CancerConnect News: The U.S. Food and Drug Administration (FDA) has approved Adcetris (brentuximab vedotin) in combination with chemotherapy in adult patients with previously untreated Stage III or IV classical Hodgkin lymphoma. The approval is based on the successful outcome of the ECHELON-1 clinical trial that compared Adcetris plus AVD (Adriamycin, vinblastine and dacarbazine) to ABVD […]

View full entry

Tags: adcetris, brentuximab, classical, hodgkin lymphoma, Hodgkin's Lymphoma, News, Precision Cancer Medicine, vedotin